Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
-17.8M
-
Total reported value, excl. options
-
$10M
-
Value change
-
-$8.58M
-
Number of buys
-
13
-
Number of sells
-
-38
-
Price
-
$0.28
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q2 2025
68 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q2 2025.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 153M outstanding shares and own 23.25% of the company stock.
Largest 10 shareholders include Telemark Asset Management, LLC (8.28M shares), Wilmington Savings Fund Society, FSB (6.1M shares), Birchview Capital, LP (5.74M shares), VANGUARD GROUP INC (3.79M shares), PERCEPTIVE ADVISORS LLC (2.17M shares), Monashee Investment Management LLC (2M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.07M shares), PERKINS CAPITAL MANAGEMENT INC (1.06M shares), GSA CAPITAL PARTNERS LLP (931K shares), and Balyasny Asset Management L.P. (860K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.